Idaho Healthcare Hub: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Healthcare Hub.

Press releases published on June 25, 2026

Jun. 25, 2026

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

Indeterminate GlobeNewswire

Jun. 25, 2026

AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet

Indeterminate GlobeNewswire

Jun. 25, 2026

Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Indeterminate GlobeNewswire

Jun. 25, 2026

Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026

Indeterminate GlobeNewswire

Jun. 25, 2026

Satellos to Present Clinical Program Updates at ICNMD 2026

Indeterminate GlobeNewswire

Jun. 25, 2026

Verano to Report Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire

Jun. 25, 2026

INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™

Indeterminate GlobeNewswire

Jun. 25, 2026

Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis

Indeterminate GlobeNewswire

Jun. 25, 2026

Montauk Brewing Kicks Off Summer with 14th Anniversary Celebration, Limited Brew Barn Release and Beach Cleanup

Indeterminate GlobeNewswire

Jun. 25, 2026

Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX

Indeterminate GlobeNewswire

Jun. 25, 2026

Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial

Indeterminate GlobeNewswire

Jun. 25, 2026

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

Indeterminate GlobeNewswire

Jun. 25, 2026

Leads Biolabs Announces Partner Oblenio Bio’s $62 Million Oversubscribed Series B Financing to Advance Tri-Specific T-Cell Engager LBL‑051 for Autoimmune Diseases into Clinical Development

Indeterminate GlobeNewswire

Jun. 25, 2026

ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement

Indeterminate GlobeNewswire

Jun. 25, 2026

ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform

Indeterminate GlobeNewswire

Jun. 25, 2026

Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development

Indeterminate GlobeNewswire

Jun. 25, 2026

BrewDog Inverurie Reopens with New Community Champions Model

Indeterminate GlobeNewswire

Jun. 25, 2026

Young workers willing to make career trade-offs for jobs with pensions: new research from HOOPP and Abacus Data

Indeterminate GlobeNewswire

Jun. 25, 2026

New CAOT project to support internationally educated OTs in Canada

Indeterminate GlobeNewswire

Jun. 25, 2026

Un nouveau projet de l’ACE pour soutenir les ergothérapeutes diplômés à l’étranger au Canada

Indeterminate GlobeNewswire